Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/9041464

Download in:

View as

General Info

PMID
9041464